Jefferies Group LLC Sarepta Therapeutics, Inc. Transaction History

Jefferies Group LLC

$10.2 Billion
Q3 2022

A detailed history of Jefferies Group LLC transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Jefferies Group LLC holds 57,628 shares of SRPT stock, worth $6.03 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

57,628

Previous 86,619 33.47%

Holding current value

$6.03 Million

Previous $6.49 Million 1.88%

% of portfolio

0.06%

Previous 0.06%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Sep 21, 2023	SELL	$75.71 - $119.24 $2.19 Million - $3.46 Million	-28,991 Reduced 33.47%	57,628 $6.37 Million
Q3 2022 Nov 14, 2022	SELL	$75.71 - $119.24 $2.19 Million - $3.46 Million	-28,991 Reduced 33.47%	57,628 $6.37 Million
Q2 2022 Sep 21, 2023	BUY	$62.69 - $88.44 $355,264 - $501,189	5,667 Added 7.0%	86,619 $6.49 Million
Q2 2022 Aug 15, 2022	BUY	$62.69 - $88.44 $355,264 - $501,189	5,667 Added 7.0%	86,619 $6.49 Million
Q1 2022 Sep 21, 2023	BUY	$63.15 - $90.42 $4.33 Million - $6.2 Million	68,541 Added 552.26%	80,952 $6.32 Million
Q1 2022 May 16, 2022	BUY	$63.15 - $90.42 $4.33 Million - $6.2 Million	68,541 Added 552.26%	80,952 $6.32 Million
Q4 2021 Sep 21, 2023	BUY	$77.28 - $99.42 $919,786 - $1.18 Million	11,902 Added 2338.31%	12,411 $1.12 Million
Q4 2021 Feb 14, 2022	BUY	$77.28 - $99.42 $959,122 - $1.23 Million	12,411 New	12,411 $1.12 Million
Q3 2021 Nov 15, 2021	SELL	$65.97 - $92.48 $33,578 - $47,072	-509 Closed	0 $0
Q2 2021 Sep 21, 2023	BUY	$69.38 - $86.75 $19,148 - $23,943	276 Added 118.45%	509 $39,000
Q2 2021 Aug 16, 2021	BUY	$69.38 - $86.75 $19,148 - $23,943	276 Added 118.45%	509 $40,000
Q1 2021 Sep 21, 2023	SELL	$72.25 - $168.95 $712,312 - $1.67 Million	-9,859 Reduced 97.69%	233 $17,000
Q1 2021 May 14, 2021	SELL	$72.25 - $168.95 $712,312 - $1.67 Million	-9,859 Reduced 97.69%	233 $17,000
Q4 2020 Sep 21, 2023	SELL	$125.56 - $178.74 $5.97 Million - $8.5 Million	-47,536 Reduced 82.49%	10,092 $1.72 Million
Q4 2020 Feb 16, 2021	BUY	$125.56 - $178.74 $85,757 - $122,079	683 Added 7.26%	10,092 $1.72 Million
Q3 2020 Nov 13, 2020	SELL	$127.12 - $172.34 $20,720 - $28,091	-163 Reduced 1.7%	9,409 $1.32 Million
Q2 2020 Aug 14, 2020	SELL	$93.0 - $171.7 $217,434 - $401,434	-2,338 Reduced 19.63%	9,572 $1.54 Million
Q1 2020 May 15, 2020	SELL	$82.38 - $131.64 $1.71 Million - $2.74 Million	-20,812 Reduced 63.6%	11,910 $1.17 Million
Q4 2019 Feb 13, 2020	SELL	$76.53 - $135.58 $867,237 - $1.54 Million	-11,332 Reduced 25.72%	32,722 $4.22 Million
Q3 2019 Nov 13, 2019	BUY	$72.81 - $156.91 $1.34 Million - $2.89 Million	18,437 Added 71.97%	44,054 $3.32 Million
Q2 2019 Aug 14, 2019	BUY	$112.21 - $151.95 $1.21 Million - $1.64 Million	10,772 Added 72.56%	25,617 $3.89 Million
Q1 2019 May 15, 2019	BUY	$106.67 - $151.68 $122,457 - $174,128	1,148 Added 8.38%	14,845 $1.77 Million
Q4 2018 Feb 14, 2019	BUY	$97.32 - $148.76 $178,874 - $273,420	1,838 Added 15.5%	13,697 $1.5 Million
Q3 2018 Nov 14, 2018	SELL	$115.31 - $161.51 $1.98 Million - $2.78 Million	-17,191 Reduced 59.18%	11,859 $1.92 Million
Q2 2018 Aug 14, 2018	BUY	$71.74 - $153.69 $2.08 Million - $4.46 Million	29,050 New	29,050 $3.84 Million
Q1 2018 May 15, 2018	SELL	$54.02 - $82.27 $2.16 Million - $3.29 Million	-40,000 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$47.64 - $56.75 $1.91 Million - $2.27 Million	40,000	40,000 $2.23 Million

Others Institutions Holding SRPT

# of Institutions

531

Shares Held

84.5M

Call Options Held

2.06M

Put Options Held

1.52M

View Full List

About Sarepta Therapeutics, Inc.

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $9.17B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

More about SRPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Group LLC with notifications on news.

Account

Jefferies Group LLC Sarepta Therapeutics, Inc. Transaction History